Welcome to Critical Mass, Law.com’s weekly briefing on class actions and mass torts. Here’s what’s happening: Could some—or all—of the $289 million Roundup verdict get reversed? Labaton cuts a deal to end a lengthy over-billing inquiry, but the judge still has questions. And find out which law firm won last week’s defense verdict in the latest mesothelioma trial over Johnson & Johnson’s baby powder.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]